Crossref
Advances in Cellular Immunotherapy in Hematologic Malignancies
Advances in Oncology · 2021
DOI: 10.1016/j.yao.2021.02.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Oncology, 2021. Verfasst von Mahmoud R. Gaballa und 1 weiteren Autor:innen. Die Arbeit nennt 65 Literaturangaben. Gefördert von: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Gaballa, M. R., & Kebriaei, P. (2021). Advances in Cellular Immunotherapy in Hematologic Malignancies. Advances in Oncology. https://doi.org/10.1016/j.yao.2021.02.021
Vancouver
Gaballa MR, Kebriaei P. Advances in Cellular Immunotherapy in Hematologic Malignancies. Advances in Oncology. 2021. doi:10.1016/j.yao.2021.02.021
BibTeX
@article{Gaballa2021,
author = {Gaballa, Mahmoud R. and Kebriaei, Partow},
title = {Advances in Cellular Immunotherapy in Hematologic Malignancies},
journal = {Advances in Oncology},
year = {2021},
doi = {10.1016/j.yao.2021.02.021}
}
EUVIMED